Specific antibodies to recombinant allergens of <it>Aspergillus fumigatus </it>in cystic fibrosis patients with ABPA
<p>Abstract</p> <p>Background</p> <p><it>Aspergillus fumigatus</it>, a widely distributed fungus, has been implicated in causing life threatening infections as well as severe asthma and allergic diseases in man. Allergic affliction like allergic bronchopulmo...
Main Authors: | Moss Richard B, Knutsen Alan P, Kurup Viswanath P, Bansal Naveen K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-07-01
|
Series: | Clinical and Molecular Allergy |
Online Access: | http://www.clinicalmolecularallergy.com/content/4/1/11 |
Similar Items
-
Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD
by: Tiew, Pei Yee, et al.
Published: (2023) -
Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Jingming Zhao, et al.
Published: (2018-11-01) -
Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
by: Valentina Fainardi, et al.
Published: (2022-03-01) -
Infection, Allergy, and Inflammation: The Role of <i>Aspergillus fumigatus</i> in Cystic Fibrosis
by: T. Spencer Poore, et al.
Published: (2023-08-01) -
Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
by: Moïse Michel, et al.
Published: (2022-06-01)